Intentar ORO - Gratis
Transforming Diagnostics and Personalized Medicine Amidst Challenges
The Business Guardian
|December 29, 2024
Genomic testing, an advanced diagnostic tool, delves deep into the analysis of DNA, RNA, and proteomics to uncover genetic mutations, assess disease risks, and provide critical insights for medical decisions.

The field has seen transformative progress with the advent of technologies like next-generation sequencing, enabling the early detection of diseases, particularly cancers.
This cutting-edge approach has significantly enhanced diagnostic precision, making it a cornerstone in personalized medicine. However, challenges persist. Restricted insurance coverage, high costs, and the complexity of interpreting vast genomic data continue to hinder its widespread adoption.
These obstacles underscore the need for robust frameworks to ensure accessibility and affordability.
To shed light on this evolving field and its implications for healthcare, we turn to Dr. Kirti Chadha, Chief Scientific and Innovation Officer at Metropolis Healthcare Limited.
Q: What is genomic testing, and how does it differ from traditional diagnostic tests?
A: In 2003, the Human Genome Project that mapped an understanding of all human genes was completed and changed the entire testing scope impacting every clinical segment. Although genetic testing started way back in 1950 when Down (trisomy 21) and other syndromes were diagnosed by cytogenetic methods & evolved further in 1990s when the novel technique of PCR accelerated molecular genetic testing by enabling targeted testing for known pathogenic variants, it accelerated only when Next Generation Sequencing & other newer technologies added to the understanding of the human genome and its impact on disease.
Testing has now evolved from comprehensive gene panels to exome and genome sequencing as routine tests, thereby revolutionizing the diagnosis of rare genetic diseases among others.
As compared to traditional lab tests, genomic tests that study DNA, RNA, proteomics can identify mutations in our genes indicating if we have or not a genetic condition while also identifying our risk for developing a certain condition or passing on a genetic disorder to the next generation.
Esta historia es de la edición December 29, 2024 de The Business Guardian.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE The Business Guardian

The Business Guardian
‘Capex, Opex subsidies in mineral scheme to boost recycling infra’
Provision of both capital expenditure (Capex) and operational expenditure (Opex) subsidies under Rs 1,500 crore incentive scheme for Critical Mineral Recycling will accelerate the establishment of advanced recycling infrastructure, said industry body India Energy Storage Alliance (IESA) while welcoming the Centre's move.
2 mins
September 21, 2025

The Business Guardian
Why 2 nm chips matter in India’s chip revolution
India has taken another big step in its semiconductor journey with the recent inauguration of ARM's new design office in Bengaluru.
2 mins
September 21, 2025
The Business Guardian
GOVT ACTIVATES PORTAL FOR GST COMPLAINTS
The Ministry of Consumer Affairs, Food & Public Distribution on Saturday announced the activation of a dedicated category on the INGRAM portal to handle anticipated consumer queries and complaints on the National Consumer Helpline (NCH), following the implementation of revised GST charges, rates, and exemptions effective from September 22.
2 mins
September 21, 2025
The Business Guardian
BofA sees positive outlook for Paytm, citing soundbox, AI
Paytm (One97 Communications Limited), India's full stack merchant payments leader, is showing steady momentum across its core
1 min
September 21, 2025

The Business Guardian
GST CUTS TO BOOST ECONOMY, BUT REVENUE LOSS COULD HIT BANKING SECTOR
While the government has estimated an annual revenue loss of about Rs 480 billion, due to the reduced Goods and Services Tax (GST) rates on various products, a recent report by Systematix Research has pegged the figure much higher, at nearly Rs 1.2 trillion.
1 mins
September 21, 2025

The Business Guardian
Ahead of IPO, Ganesh Consumer Products raises Rs 122 crore
Ganesh Consumer Products Ltd, a key player in packaged food products in eastern India, on Friday said it has raised over Rs 122 crore from anchor investors, ahead of its initial share-sale opening for public subscription.
1 min
September 21, 2025

The Business Guardian
Third round of India-New Zealand FTA negotiations concludes
The third round of negotiations for the India-New Zealand Free Trade Agreement (FTA) concluded successfully on Friday in Queenstown, New Zealand.
1 min
September 21, 2025
The Business Guardian
'Capex, Opex subsidies in mineral scheme to boost recycling infra'
Eligible feedstock is e-waste, Lithium Ion Battery (LIB) scrap, and scrap other than e-waste & LIB scrap, e.g. catalytic converters in end-of-life vehicles.
1 min
September 21, 2025

The Business Guardian
Zelio E-Mobility gets Sebi nod for Rs 78-cr IPO
Electric vehicle maker Zelio E-Mobility Ltd on Friday said it has received approval from capital market regulator Sebi for its SME IPO to raise Rs 78 crore.
1 min
September 21, 2025

The Business Guardian
US' H-1B fee move can have ripple effects on US innovation system
Indian IT industry body Nasscom has expressed concerns following the White House’s September 19 announcement of anew USD 100,000 annual fee on H-IB visa applications, calling the move potentially disruptive to global business continuity and the innovation ecosystem in the United States.
2 mins
September 21, 2025
Listen
Translate
Change font size